Nitric oxide and vascular reactivity in sepsis

Shock

Volumn 30, Issue SUPPL. 1, 2008, Pages 10-13

  Fernandes, Daniel ^a   Assreuy, Jamil ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Blood pressure; Guanylate cyclase; Potassium channels; Septic shock; Vasoplegia

Indexed keywords

GUANYLATE CYCLASE; NITRIC OXIDE; POTASSIUM CHANNEL;

BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONFERENCE PAPER; MORBIDITY; MORTALITY; SEPSIS; SEPTIC SHOCK;

ANIMALS; BLOOD PRESSURE; GUANYLATE CYCLASE; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NITRIC OXIDE; POTASSIUM CHANNELS; SEPSIS; SHOCK, SEPTIC; TIME FACTORS;

EID: 54049129652     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181818518     Document Type: Conference Paper

References (63)

1. Quezado ZMN, Natanson C: Systemic hemodynamic abnormalities and vasopressor therapy in sepsis and septic shock. Am J Kidney Dis 20:214-222, 1992.
2. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227-242, 1990.
3. Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593-615, 2001.
4. Brandtzaeg P: Significance and pathogenesis of septic shock. Curr Top Microbiol Immunol 216:15-37, 1996.
5. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, et al.: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650, 1995.
6. Gunnett CA, Chu Y, Heistad DD, Loihl A, Faraci FM: Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase. Am J Physiol 275:H416-H421, 1998.
7. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259:H1038-H1043, 1990.
8. Fleming I, Julou-Schaeffer G, Gray GA, Parratt JR, Stoclet JC: Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol 103:1047-1052, 1991.
9. Gray GA, Schoot C, Julou-Schaeffer G, Fleming I, Parratt JR, Stoclet JC: The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 103:1218-1224, 1991.
10. Gardiner SM, Kemp PA, March JE, Bennett T: Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharmacol 116:2005-2016, 1995.
11. Silva-Santos JE, Terluk MR, Assreuy J: Differential involvement of guanylate cyclase and potassium channels in nitric oxide-induced hyporesponsiveness to phenylephrine in endotoxemic rats. Shock 17:70-76, 2002.
12. Silva-Santos JE, Assreuy J: Long-lasting changes of rat blood pressure to vasoconstrictors and vasodilators induced by nitric oxide donor infusion: involvement of potassium channels. J Pharmacol Exp Ther 290:380-387, 1999.
13. Liaudet L, Soriano FG, Szabo C: Biology of nitric oxide signaling. Crit Care Med 4:N37-N52, 2000.
14. Feihl F, Waeber B, Liaudet L: Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther 91:179-213, 2001.
15. Paya D, Gray GA, Stoclet JC: Effects of methylene blue on blood pressure and reactivity to norepinephrine in endotoxemic rats. J Cardiovasc Pharmacol 21:926-930, 1993.
16. Cheng X, Pang CC: Pressor and vasoconstrictor effects of methylene blue in endotoxaemic rats. Naunyn Schmiedebergs Arch Pharmacol 357:648-653, 1998.
17. Keaney JF Jr, Puyana JC, Francis S, Loscalzo JF, Stamler JS, Loscalzo J: Methylene blue reverses lipopolysaccharide-induced hypotension. Circ Res 74:1121-1125, 1994.
18. Zhang H, Rogiers P, Preiser JC, Spapen H, Manikis P, Metz G, Vincent JL: Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med 23:1711-1721, 1995.
19. Schneider F, Lutun P, Hasselmann M, Stoclet JC, Tempe JD: Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 18:309-311, 1992.
20. Gachot B, Bedos JP, Veber B, Wolff M, Regnier B: Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock. Intensive Care Med 21:1027-1031, 1995.
21. Preiser JC, Lejeune P, Roman A, Carlier E, De Backer D, Leeman M, Kahn RJ, Vincent JL: Methylene blue administration in septic shock: a clinical trial. Crit Care Med 23:259-264, 1995.
22. Daemen-Gubbels CR, Groeneveld PH, Groeneveld AB, van Kamp GJ, Bronsveld W, Thijs LG: Methylene blue increases myocardial function in septic shock. Crit Care Med 23:1363-1370, 1995.
23. Brown G, Frankl D, Phang T: Continuous infusion of methylene blue for septic shock. Postgrad Med 72:61261-61264, 1996.
24. Andresen M, Dougnac A, Diaz O, Hernandez G, Castillo L, Bugedo G, Alvarez M, Dagnino J: Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange. J Crit Care 13:164-168, 1998.
25. Weingartner R, Oliveira E, Oliveira ES, Sant'Anna UL, Oliveira RP, Azambuja LA, Friedman G: Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue. Braz J Med Biol Res 32:1505-1513, 1999.
26. Kirov MY, Evgenov OV, Evgenov NV, Egorina EM, Sovershaev MA, Sveinbjornsson B, Nedashkovsky EV, Bjertnaes LJ: Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med 29:1860-1867, 2001.
27. Donati A, Conti G, Loggi S, Münch C, Coltrinari R, Pelaia P, Pietropaoli P, Preiser JC: Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med 30:2271-2277, 2002.
28. Memis D, Karamanlioglu B, Yuksel M, Gemlik I, Pamukcu Z: The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care 30:755-762, 2002.
29. Schneider F: Methylene blue infusion in septic shock. Crit Care Med 23:1935-1936, 1995.
30. Marczin N, Tekeres M, Salzman AL, Szabo C: Methylene blue infusion in septic shock. Crit Care Med 23:1936-1938, 1995.
31. Koch HJ: Effects of methylene blue in septic shock. Crit Care Med 24:1093-1094, 1996.
32. Donati A, Preiser JC: Methylene blue: An old-timer or a compound ready for revival. Crit Care Med 34:2862-2863, 2006.
33. Fernandes D, Silva-Santos JE, Duma D, Villela CG, Barja-Fidalgo C, Assreuy J: Nitric oxide-dependent reduction in soluble guanylate cyclase funcionality accounts for early lipopolysaccharide-induced changes in vascular reactivity. Mol Pharmacol 69:983-990, 2006.
34. De Kimpe SJ, Van Heuven-Nolsen D, van Amsterdam JG, Radomski MW, Nijkamp FP: Induction of nitric oxide release by interferon-gamma inhibits vasodilation and cyclic GMP increase in bovine isolated mesenteric arteries. J Pharmacol Exp Ther 268:910-915, 1994.
35. Tsuchida S, Hiraoka M, Sudo M, Kigoshi S, Muramatsu I: Attenuation of sodium nitroprusside responses after prolonged incubation of rat aorta with lipopolysaccharide. Am J Physiol 267:H2305-H2310, 1994.
36. Papapetropoulos A, Abou-Mohamed G, Marczin N, Murad F, Caldwell RW, Catravas JD: Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to lipopolysaccharide or interleukin-1 beta. Br J Pharmacol 118:1359-1366, 1996.
37. Scott WS, Nakayama DK: Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle. J Surg Res 80:309-314, 1998.
38. Takata M, Filippov G, Liu H, Ichinose F, Janssens S, Bloch DB, Bloch KD: Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms. Am J Physiol Lung Cell Mol Physiol 280:L272-L278, 2001.
39. Kitazono T, Faraci FM, Taguchi H, Heistad DD: Role of potassium channels in cerebral blood vessels. Stroke 26:1713-1723, 1995.
40. Nelson MT, Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268:C799-C822, 1995.
41. Robertson BE, Schubert R, Hescheler J, Nelson MT: cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol 265:C299-C303, 1993.
42. Taniguchi J, Furukawa KI, Shigekawa M: Maxi K+ channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pflugers Arch 423:167-172, 1993.
43. Archer SL, Huang JM, Nelson DP, Shultz PJ, Weir EK: Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A 91:7583-7587, 1994.
44. Wu CC, Chen SJ, Yen MH: Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats. Am J Physiol 275:H1148-H1157, 1998.
45. Bolotina VM, Najibe S, Palacino JJ, Pagano JP, Cohen RA: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368:850-853, 1994.
46. Landry DW, Oliver JA: The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest 89:2071-2074, 1992.
47. Hall S, Turcato S, Clapp L: Abnormal activation of K+ channels underlies relaxation to bacterial lipopolysaccharide in rat aorta. Biochem Biophys Res Commun 224:184-190, 1996.
48. Chen SJ, Wu CC, Yang SN, Lin CI, Yen MH: Abnormal activation of K(+) channels in aortic smooth muscle of rats with endotoxic shock: electrophysiological and functional evidence. Br J Pharmacol 131:213-222, 2000.
49. Chen SJ, Wu CC, Yen MH: Role of nitric oxide and K+-channels in vascular hyporeactivity induced by endotoxin. Naunyn Schmiedebergs Arch Pharmacol 359:493-499, 1999.
50. Chen CC, Lin YC, Chen SA, Luk HN, Ding PY, Chang MS, Chiang CE: Shortening of cardiac action potentials in endotoxic shock in guinea pigs is caused by an increase in nitric oxide activity and activation of the adenosine triphosphate-sensitive potassium channel. Crit Care Med 28:1713-1720, 2000.
51. Terluk MR, Silva-Santos JE, Assreuy J: Involvement of soluble guanylate cyclase and calcium-activated potassium channels in the long- lasting hyporesponsiveness to phenylephrine induced by nitric oxide in the rat aorta. Naunyn Schmiedebergs Arch Pharmacol 361:477-483, 2000.
52. Fernandes D, Silva-Santos JE, Assreuy J: Nitric oxide-induced inhibition of mouse paw edema: involvement of soluble guanylate cyclase and potassium channels. Inflamm Res 51:377-384, 2002.
53. Fernandes D, Assreuy J: Involvement of guanylate cyclase and potassium channels on the delayed phase of mouse carrageenan-induced paw oedema. Eur J Pharmacol 501:209-214, 2004.
54. Vanelli G, Hussain SN, Aguggini G: Glibenclamide, a blocker of ATP-sensitive potassium channels, reverses endotoxin-induced hypotension in pig. Exp Physiol 80:167-170, 1995.
55. Vanelli G, Hussain SN, Dimori M, Aguggini G: Cardiovascular responses to glibenclamide during endotoxaemia in the pig. Vet Res Commun 21:187-200, 1997.
56. Wu CC, Thiemermann C, Vane JR: Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat. Br J Pharmacol 114:1273-1281, 1995.
57. Taguchi H, Heistad DD, Chu Y, Rios CD, Ooboshi H, Faraci FM: Vascular expression of inducible nitric oxide synthase is associated with activation of Ca(++)-dependent K+ channels. J Pharmacol Exp Ther 279:1514-1519, 1996.
58. Sorrentino R, d'Emmanuele di Villa Bianca R, Lippolis L, Sorrentino L, Autore G, Pinto A: Involvement of ATP-sensitive potassium channels in a model of a delayed vascular hyporeactivity induced by lipopolysaccharide in rats. Br J Pharmacol 127:1447-1453, 1999.
59. Preiser JC, Zhang H, Debelle F, Fesler P, Kafi SA, Naeije R, Vincent JL: Hemodynamic effects of glibenclamide during endotoxemia: contrasting findings in vitro versus in vivo. Shock 19:223-228, 2003.
60. Warrilow S, Egi M, Bellomo R: Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock. Crit Care Med 34:980-985, 2006.
61. Morelli A, Lange M, Ertmer C, Broeking K, Van Aken H, Orecchioni A, Rocco M, Bachetoni A, Traber DL, Landoni G, et al.: Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport. Shock 28:530-535, 2007.
62. Pickkers P, Dorresteijn MJ, Bouw MP, van der Hoeven JG, Smits P: In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia. Circulation 114:414-421, 2006.
63. Cauwels A, Brouckaert P: Critical role for small and large conductance calcium-dependent potassium channels in endotoxemia and TNF toxicity. Shock 29:577-582, 2007.